Stocktoria
HST Global, Inc. HSTC
OTC · stock · Pharmaceutical Preparations · website · IPO 1986-09-24
HST Global, Inc. financials (annual, from 10-K)
Bars are annual figures from 2014 to 2023; red bars are negative (a loss or cash outflow).
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Operating income | -$140,907 | -$141,035 | -$145,718 | -$207,978 | -$151,554 | -$142,587 | -$152,995 | -$137,274 | -$160,047 | -$148,954 |
| Interest expense | $5,303 | $4,039 | $2,642 | $1,014 | $17,874 | $35,748 | -$35,748 | -$35,748 | $35,748 | $35,748 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Net income | -$146,210 | -$145,074 | -$148,360 | -$208,992 | $426,572 | -$178,335 | -$165,092 | -$173,022 | -$195,795 | -$184,702 |
| Operating cash flow | -$20,906 | -$21,035 | -$29,836 | -$26,971 | -$91,905 | -$21,091 | -$29,874 | -$21,930 | -$17,569 | -$24,550 |
| Cash & equivalents | $1,526 | $190 | $225 | $660 | $1,955 | $0 | $291 | $465 | $195 | $164 |
| Total assets | $1,526 | $190 | $225 | $660 | $1,955 | $0 | $291 | $465 | $195 | $164 |
| Total liabilities | $593,593 | $446,047 | $301,008 | $153,083 | $5,385 | $3.4M | $3.2M | $3.0M | $2.9M | $2.7M |
| Shareholders' equity | -$592,067 | -$445,857 | -$300,783 | -$152,423 | -$3,430 | -$3.4M | -$3.2M | -$3.0M | -$2.9M | -$2.7M |
Growth · year-over-year
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income growth | — | — | — | -149.0% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000797564 · US · as of 2023-12-31. facts plus Stocktoria's own computed scores — not investment advice.